“Having mothers take DHA supplements during the newborn period to prevent bronchopulmonary dysplasia in their very preterm infants cannot be recommended at this point,”

Consumption of DHA supplements, an omega-3 fatty acid, by breastfeeding mothers is ineffective in preventing bronchopulmonary dysplasia in preterm infants born before the 29th week of pregnancy. This is the main conclusion of a Canada-wide study published today in the Journal of the American Medical Association (JAMA).

“Bronchopulmonary dysplasia is a chronic inflammatory lung disease that affects half of preterm infants, causing significant breathing difficulties that can make them become dependent on ventilators and oxygen for months,” explained the study’s lead author, Dr. Isabelle Marc, pediatrician, professor at the Université Laval Faculty of Medicine and researcher at the CHU de Québec–Université Laval Research Centre. “Babies with bronchopulmonary dysplasia are at greater risk for neurodevelopmental disabilities, respiratory issues, and, in rare cases, death.” [MORE]